Schedule iii

By

28 May 2026

Tilray's U.S. Market Bet Leaves Investors Waiting on Federal Policy, Not Earnings

Tilray Brands has spent the better part of two years doing the unglamorous work of getting its house in order - tightening its balance sheet, growing international medical cannabis sales, and inching

• Tilray Brands

By

11 May 2026

Federal Medical Marijuana Rescheduling Splits Colorado's Cannabis Market in Two

U.S. Attorney General Todd Blanche signed an order this week immediately rescheduling state-licensed medical marijuana from Schedule I to Schedule III under the Controlled Substances Act - a shift

• Colorado cannabis market

By

03 May 2026

Cannabis Rescheduling Leaves Banking Barriers Largely Intact for Most Operators

The federal reclassification of cannabis from Schedule I to Schedule III was supposed to mark a turning point. For tax purposes and research access, it does. For the majority of cannabis businesses

• Cannabis Rescheduling

By

28 Apr 2026

Federal Marijuana Rescheduling Order Gives Hawai'i Lawmakers New Hope for Cannabis Reform

After years of watching his recreational cannabis bills die quiet deaths in the Hawai'i State Legislature, Big Island Representative David Tarnas has found an unlikely source of optimism: the Trump

• Federal Marijuana Rescheduling